Pubblicazioni
scientifiche

Dompé farmaceutici S.p.A. Socio Unico / Capitale sociale € 50.000.000,00
REA MI 289519 - Registro Imprese di Milano / Codice Fiscale e Partita IVA (VAT) IT00791570153

Pubblicazioniscientifiche

I nostri ricercatori contribuiscono al progresso della conoscenza scientifica attraverso pubblicazioni realizzate insieme ai centri e alle università con cui collaboriamo in tutto il mondo.

1,3-Dibromo-1,1-difluoro-2-propanone as a Useful Synthon for a Chemoselective Preparation of 4-Bromodifluoromethyl Thiazoles

Efficacy of ketoprofen lysine salt and paracetamol/acetaminophen to reduce pain during rapid maxillary expansion: A randomized controlled clinical trial

Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

IL-6 and CXCL8 Mediate Osteosarcoma-Lung Interactions Critical to Metastasis

Antinociceptive Effect of Two Novel Transient Receptor Potential Melastatin 8 Antagonists in Acute and Chronic Pain Models in Rat

Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat

Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors

Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib

CXCR2 Is Critical for Bacterial Control and Development of Joint Damage and Pain in Staphylococcus Aureus-Induced Septic Arthritis in Mouse

Si è verificato un errore durante la ricerca, riprovare più tardi.

Rapporto tra numero documenti e citazioni

Numero ponderato di pubblicazioni per area tematica

Pubblicazioni
scientifiche